SerineThreonine Protein Kinase Pim 1 - Pipeline Review, H2 2017, outlays comprehensive information on the Serine/Threonine Protein Kinase Pim 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type.
Serine/Threonine Protein Kinase Pim 1 (Oncogene PIM1 or PIM1 or EC 184.108.40.206) - Proto-oncogene serine/threonine-protein kinase Pim-1 is an enzyme encoded by the PIM1 gene. It promotes cell cycle progression and tumorigenesis by down-regulating expression of a regulator of cell cycle progression CDKN1B at both transcriptional and post-translational levels.
It mediates survival signaling through phosphorylation of BAD which induces release of the anti-apoptotic protein Bcl-X (L)/BCL2L1.
Complete Report Available at www.themarketreports.com/report/se…e-review-h2-2017
Reasons to access
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand the targeted therapy areas and indications for Serine/Threonine Protein Kinase Pim 1
- Identify the use of drugs for target identification and drug repurposing
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Serine/Threonine Protein Kinase Pim 1 development landscape
Access this Report at www.themarketreports.com/report/941494
List of Figures
- Number of Products under Development by Stage of Development, H2 2017
- Number of Products under Development by Therapy Areas, H2 2017
- Number of Products under Development by Top 10 Indications, H2 2017
- Number of Products by Stage and Mechanism of Actions, H2 2017
- Number of Products by Stage and Route of Administration, H2 2017
- Number of Products by Stage and Molecule Type, H2 2017
Inquire About this Report at www.themarketreports.com/report/ask-your-query/941494
Category: Market Research Publishers and RetailersCompany about: The Market Reports aims to provide the best industry and market reports to a seeker. We are looking forward to a place where we are the one stop destination for all the report seekers irrespective of any country, category, domain, etc. We are always open on call and email (24*7) to your queries and very clean with the business methodology. Since we are dealing with so many Publishers, we can actually give you what suits best in accordance to your requirements.
For more information: